78 related articles for article (PubMed ID: 4066076)
1. Fosmidomycin, a new phosphonic acid antibiotic. Part II: 1. Human pharmacokinetics. 2. Preliminary early phase IIa clinical studies.
Kuemmerle HP; Murakawa T; Sakamoto H; Sato N; Konishi T; De Santis F
Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):521-8. PubMed ID: 4066076
[TBL] [Abstract][Full Text] [Related]
2. Fosmidomycin: a new phosphonic acid antibiotic. Part I: Phase I tolerance studies.
Kuemmerle HP; Murakawa T; Soneoka K; Konishi T
Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):515-20. PubMed ID: 4066075
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic evaluation of fosmidomycin, a new phosphonic acid antibiotic.
Kuemmerle HP; Murakawa T; De Santis F
Chemioterapia; 1987 Apr; 6(2):113-9. PubMed ID: 3594633
[TBL] [Abstract][Full Text] [Related]
4. Single- and repeated-dose pharmacokinetics of intramuscular thiocolchicoside in healthy volunteers.
Weinling E; Sandouk P; Debray M; Scherrmann JM
Int J Clin Pharmacol Ther; 1999 Oct; 37(10):503-9. PubMed ID: 10543318
[TBL] [Abstract][Full Text] [Related]
5. [Fosfomycin-trometamol (monuril): pharmacokinetics and food-drug interactions].
Muller-Serieys C; Bergogne-Berezin E; Joly-Guillou ML
Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):753-6. PubMed ID: 3309810
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of fosmidomycin, a new phosphonic acid antibiotic.
Murakawa T; Sakamoto H; Fukada S; Konishi T; Nishida M
Antimicrob Agents Chemother; 1982 Feb; 21(2):224-30. PubMed ID: 7073262
[TBL] [Abstract][Full Text] [Related]
7. Pharmacodisposition of thiamphenicol in rabbits.
Abd El-Aty AM; Abo El Sooud K; Goudah AM
Dtsch Tierarztl Wochenschr; 2001 Sep; 108(9):393-6. PubMed ID: 11599443
[TBL] [Abstract][Full Text] [Related]
8. Human intravenous and intramuscular pharmacokinetics of amoxicillin.
Mastrandrea V; Ripa S; La Rosa F; Tarsi R
Int J Clin Pharmacol Res; 1984; 4(3):209-12. PubMed ID: 6490239
[TBL] [Abstract][Full Text] [Related]
9. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
Bergman AJ; Stevens C; Zhou Y; Yi B; Laethem M; De Smet M; Snyder K; Hilliard D; Tanaka W; Zeng W; Tanen M; Wang AQ; Chen L; Winchell G; Davies MJ; Ramael S; Wagner JA; Herman GA
Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of tiapride and absolute bioavailability of three extravascular forms.
Rey E; d'Athis P; Richard MO; de Lauture D; Olive G
Int J Clin Pharmacol Ther Toxicol; 1982 Feb; 20(2):62-7. PubMed ID: 7061180
[TBL] [Abstract][Full Text] [Related]
12. Phase I and pharmacokinetic studies of high-dose uridine intended for rescue from 5-fluorouracil toxicity.
Leyva A; van Groeningen CJ; Kraal I; Gall H; Peters GJ; Lankelma J; Pinedo HM
Cancer Res; 1984 Dec; 44(12 Pt 1):5928-33. PubMed ID: 6498850
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
Smith WB; Dowell JA; Pratt RD
Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of cefoperazone after single and multiple doses.
Ripa S; La Rosa F; Dainelli B; Ecari U; Ruffilli MP
Int J Clin Pharmacol Res; 1986; 6(2):171-5. PubMed ID: 3721648
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic comparison between fosfomycin and other phosphonic acid derivatives.
Bergan T
Chemotherapy; 1990; 36 Suppl 1():10-8. PubMed ID: 2085981
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol.
Lintz W; Barth H; Becker R; Frankus E; Schmidt-Böthelt E
Arzneimittelforschung; 1998 May; 48(5):436-45. PubMed ID: 9638309
[TBL] [Abstract][Full Text] [Related]
17. Intravenous and intramuscular pharmacokinetics of a single-daily dose of disodium-fosfomycin in cattle, administered for 3 days.
Sumano LH; Ocampo CL; Gutierrez OL
J Vet Pharmacol Ther; 2007 Feb; 30(1):49-54. PubMed ID: 17217401
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of the gastrokinetic agent mosapride citrate after single and multiple oral administrations in healthy subjects.
Sakashita M; Yamaguchi T; Miyazaki H; Sekine Y; Nomiyama T; Tanaka S; Miwa T; Harasawa S
Arzneimittelforschung; 1993 Aug; 43(8):867-72. PubMed ID: 8216445
[TBL] [Abstract][Full Text] [Related]
19. Absolute bioavailability of amezinium. A cross-over study after i.v. and p.o. application.
Kaumeier S; Kehrhahn OH; Morgenthaler H; Neugebauer G
Arzneimittelforschung; 1981; 31(9a):1653-7. PubMed ID: 7197980
[TBL] [Abstract][Full Text] [Related]
20. Effect of oral charcoal and urine pH on sotalol pharmacokinetics.
Kärkkäinen S; Neuvonen PJ
Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):441-6. PubMed ID: 6092287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
